▶ 調査レポート

モノクローナル抗体治療の世界市場2017

• 英文タイトル:Global Monoclonal Antibody Therapeutics Market Size, Status and Forecast 2022

QYResearchが調査・発行した産業分析レポートです。モノクローナル抗体治療の世界市場2017 / Global Monoclonal Antibody Therapeutics Market Size, Status and Forecast 2022 / A04108336資料のイメージです。• レポートコード:A04108336
• 出版社/出版日:QYResearch / 2017年3月1日
• レポート形態:英文、PDF、107ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医療・製薬・バイオ
• 販売価格(消費税別)
  Single User¥356,400 (USD3,300)▷ お問い合わせ
  Enterprise¥712,800 (USD6,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、モノクローナル抗体治療の世界市場について調査・分析し、モノクローナル抗体治療のメーカー別販売量、市場シェア分析、種類別販売分析、用途別販売分析、地域別販売分析(アメリカ、中国、ヨーロッパ、日本、東南アジア、インド)、価格動向、企業動向、モノクローナル抗体治療産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。(※Sales:モノクローナル抗体治療の販売量、Revenue:モノクローナル抗体治療の売上高)

・モノクローナル抗体治療市場概要
・モノクローナル抗体治療のメーカー別販売量・メーカー別シェア
・モノクローナル抗体治療の世界市場:種類別販売量・市場シェア
・モノクローナル抗体治療の世界市場:用途別販売量・市場シェア
・モノクローナル抗体治療の世界市場:地域別販売量・市場シェア
・モノクローナル抗体治療のアメリカ市場規模
・モノクローナル抗体治療の中国市場規模
・モノクローナル抗体治療のヨーロッパ市場規模
・モノクローナル抗体治療の日本市場規模
・モノクローナル抗体治療の東南アジア市場規模
・モノクローナル抗体治療のインド市場規模
・モノクローナル抗体治療のメーカー別分析(企業概要、事業概要、商品概要、収益、価格等)
・モノクローナル抗体治療のコスト分析・価格動向
・モノクローナル抗体治療の産業チェーン(サプライチェーン分析)
・モノクローナル抗体治療のマーケティング戦略・販売チャネル、流通業者
・モノクローナル抗体治療市場への影響要因分析
・モノクローナル抗体治療の世界市場予測
・モノクローナル抗体治療のアメリカ市場予測
・モノクローナル抗体治療の中国市場予測
・モノクローナル抗体治療のヨーロッパ市場予測
・モノクローナル抗体治療の日本市場予測
・モノクローナル抗体治療の東南アジア市場予測
・モノクローナル抗体治療のインド市場予測
・モノクローナル抗体治療の種類別世界市場予測
・モノクローナル抗体治療の用途別世界市場予測
...

This report studies the global Monoclonal Antibody Therapeutics market, analyzes and researches the Monoclonal Antibody Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Bayer
F. Hoffmann-La Roche
Pfizer
Sanofi
GlaxoSmithKline
Merck
Novartis
AbbVie
Amgen
Johnson & Johnson
Bristol-Myers Squibb Company
Biogen

Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia

Market segment by Type, Monoclonal Antibody Therapeutics can be split into
Humanized Antibody
Human Mouse Chimeric Antibody

Market segment by Application, Monoclonal Antibody Therapeutics can be split into
Cancer
Autoimmune Diseases
Infection
Hematological Diseases
Ophthalmological Diseases
Others

レポート目次

Table of Contents

Global Monoclonal Antibody Therapeutics Market Size, Status and Forecast 2022
1 Industry Overview of Monoclonal Antibody Therapeutics
1.1 Monoclonal Antibody Therapeutics Market Overview
1.1.1 Monoclonal Antibody Therapeutics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Monoclonal Antibody Therapeutics Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Monoclonal Antibody Therapeutics Market by Type
1.3.1 Humanized Antibody
1.3.2 Human Mouse Chimeric Antibody
1.4 Monoclonal Antibody Therapeutics Market by End Users/Application
1.4.1 Cancer
1.4.2 Autoimmune Diseases
1.4.3 Infection
1.4.4 Hematological Diseases
1.4.5 Ophthalmological Diseases
1.4.6 Others

2 Global Monoclonal Antibody Therapeutics Competition Analysis by Players
2.1 Monoclonal Antibody Therapeutics Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 Bayer
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Monoclonal Antibody Therapeutics Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 F. Hoffmann-La Roche
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Monoclonal Antibody Therapeutics Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Pfizer
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Monoclonal Antibody Therapeutics Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Sanofi
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Monoclonal Antibody Therapeutics Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 GlaxoSmithKline
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Monoclonal Antibody Therapeutics Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Merck
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Monoclonal Antibody Therapeutics Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Novartis
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Monoclonal Antibody Therapeutics Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 AbbVie
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Monoclonal Antibody Therapeutics Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Amgen
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Monoclonal Antibody Therapeutics Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Johnson & Johnson
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Monoclonal Antibody Therapeutics Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Bristol-Myers Squibb Company
3.12 Biogen

4 Global Monoclonal Antibody Therapeutics Market Size by Type and Application (2012-2017)
4.1 Global Monoclonal Antibody Therapeutics Market Size by Type (2012-2017)
4.2 Global Monoclonal Antibody Therapeutics Market Size by Application (2012-2017)
4.3 Potential Application of Monoclonal Antibody Therapeutics in Future
4.4 Top Consumer/End Users of Monoclonal Antibody Therapeutics

5 United States Monoclonal Antibody Therapeutics Development Status and Outlook
5.1 United States Monoclonal Antibody Therapeutics Market Size (2012-2017)
5.2 United States Monoclonal Antibody Therapeutics Market Size and Market Share by Players (2016 and 2017)

6 EU Monoclonal Antibody Therapeutics Development Status and Outlook
6.1 EU Monoclonal Antibody Therapeutics Market Size (2012-2017)
6.2 EU Monoclonal Antibody Therapeutics Market Size and Market Share by Players (2016 and 2017)

7 Japan Monoclonal Antibody Therapeutics Development Status and Outlook
7.1 Japan Monoclonal Antibody Therapeutics Market Size (2012-2017)
7.2 Japan Monoclonal Antibody Therapeutics Market Size and Market Share by Players (2016 and 2017)

8 China Monoclonal Antibody Therapeutics Development Status and Outlook
8.1 China Monoclonal Antibody Therapeutics Market Size (2012-2017)
8.2 China Monoclonal Antibody Therapeutics Market Size and Market Share by Players (2016 and 2017)

9 India Monoclonal Antibody Therapeutics Development Status and Outlook
9.1 India Monoclonal Antibody Therapeutics Market Size (2012-2017)
9.2 India Monoclonal Antibody Therapeutics Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Monoclonal Antibody Therapeutics Development Status and Outlook
10.1 Southeast Asia Monoclonal Antibody Therapeutics Market Size (2012-2017)
10.2 Southeast Asia Monoclonal Antibody Therapeutics Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
11.1 Global Monoclonal Antibody Therapeutics Market Size (Value) by Regions (2017-2022)
11.1.1 United States Monoclonal Antibody Therapeutics Revenue and Growth Rate (2017-2022)
11.1.2 EU Monoclonal Antibody Therapeutics Revenue and Growth Rate (2017-2022)
11.1.3 Japan Monoclonal Antibody Therapeutics Revenue and Growth Rate (2017-2022)
11.1.4 China Monoclonal Antibody Therapeutics Revenue and Growth Rate (2017-2022)
11.1.5 India Monoclonal Antibody Therapeutics Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Monoclonal Antibody Therapeutics Revenue and Growth Rate (2017-2022)
11.2 Global Monoclonal Antibody Therapeutics Market Size (Value) by Type (2017-2022)
11.3 Global Monoclonal Antibody Therapeutics Market Size by Application (2017-2022)

12 Monoclonal Antibody Therapeutics Market Dynamics
12.1 Monoclonal Antibody Therapeutics Market Opportunities
12.2 Monoclonal Antibody Therapeutics Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Monoclonal Antibody Therapeutics Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Monoclonal Antibody Therapeutics Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
Methodology
Analyst Introduction
Data Source

List of Tables and Figures

Figure Monoclonal Antibody Therapeutics Product Scope
Figure Global Monoclonal Antibody Therapeutics Market Size (Million USD) (2012-2017)
Table Global Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Monoclonal Antibody Therapeutics Market Share by Regions in 2016
Figure United States Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Monoclonal Antibody Therapeutics Market Share by Type in 2016
Figure Humanized Antibody Market Size (Million USD) and Growth Rate (2012-2017)
Figure Human Mouse Chimeric Antibody Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Monoclonal Antibody Therapeutics Market Share by Application in 2016
Figure Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate in Cancer (2012-2017)
Figure Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate in Autoimmune Diseases (2012-2017)
Figure Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate in Infection (2012-2017)
Figure Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate in Hematological Diseases (2012-2017)
Figure Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate in Ophthalmological Diseases (2012-2017)
Figure Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate in Others (2012-2017)
Table Monoclonal Antibody Therapeutics Market Size (Million USD) by Players (2016 and 2017)
Figure Monoclonal Antibody Therapeutics Market Size (Million USD) Share by Players in 2016
Figure Monoclonal Antibody Therapeutics Market Size (Million USD) Share by Players in 2017
Table Bayer Basic Information List
Table Monoclonal Antibody Therapeutics Business Revenue of Bayer (2012-2017)
Figure Bayer Monoclonal Antibody Therapeutics Business Revenue Market Share in 2016
Table F. Hoffmann-La Roche Basic Information List
Table Monoclonal Antibody Therapeutics Business Revenue of F. Hoffmann-La Roche (2012-2017)
Figure F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Business Revenue Market Share in 2016
Table Pfizer Basic Information List
Table Monoclonal Antibody Therapeutics Business Revenue of Pfizer (2012-2017)
Figure Pfizer Monoclonal Antibody Therapeutics Business Revenue Market Share in 2016
Table Sanofi Basic Information List
Table Monoclonal Antibody Therapeutics Business Revenue of Sanofi (2012-2017)
Figure Sanofi Monoclonal Antibody Therapeutics Business Revenue Market Share in 2016
Table GlaxoSmithKline Basic Information List
Table Monoclonal Antibody Therapeutics Business Revenue of GlaxoSmithKline (2012-2017)
Figure GlaxoSmithKline Monoclonal Antibody Therapeutics Business Revenue Market Share in 2016
Table Merck Basic Information List
Table Monoclonal Antibody Therapeutics Business Revenue of Merck (2012-2017)
Figure Merck Monoclonal Antibody Therapeutics Business Revenue Market Share in 2016
Table Novartis Basic Information List
Table Monoclonal Antibody Therapeutics Business Revenue of Novartis (2012-2017)
Figure Novartis Monoclonal Antibody Therapeutics Business Revenue Market Share in 2016
Table AbbVie Basic Information List
Table Monoclonal Antibody Therapeutics Business Revenue of AbbVie (2012-2017)
Figure AbbVie Monoclonal Antibody Therapeutics Business Revenue Market Share in 2016
Table Amgen Basic Information List
Table Monoclonal Antibody Therapeutics Business Revenue of Amgen (2012-2017)
Figure Amgen Monoclonal Antibody Therapeutics Business Revenue Market Share in 2016
Table Johnson & Johnson Basic Information List
Table Monoclonal Antibody Therapeutics Business Revenue of Johnson & Johnson (2012-2017)
Figure Johnson & Johnson Monoclonal Antibody Therapeutics Business Revenue Market Share in 2016
Table Bristol-Myers Squibb Company Basic Information List
Table Monoclonal Antibody Therapeutics Business Revenue of Bristol-Myers Squibb Company (2012-2017)
Figure Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Business Revenue Market Share in 2016
Table Biogen Basic Information List
Table Monoclonal Antibody Therapeutics Business Revenue of Biogen (2012-2017)
Figure Biogen Monoclonal Antibody Therapeutics Business Revenue Market Share in 2016
Table Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Type (2012-2017)
Figure Global Monoclonal Antibody Therapeutics Market Size (Million USD) Share by Type in 2012
Figure Global Monoclonal Antibody Therapeutics Market Size (Million USD) Share by Type in 2013
Figure Global Monoclonal Antibody Therapeutics Market Size (Million USD) Share by Type in 2014
Figure Global Monoclonal Antibody Therapeutics Market Size (Million USD) Share by Type in 2015
Figure Global Monoclonal Antibody Therapeutics Market Size (Million USD) Share by Type in 2016
Figure Global Monoclonal Antibody Therapeutics Market Size (Million USD) Share by Type in 2017
Table Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Application (2012-2017)
Figure Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Application in 2012
Figure Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Application in 2013
Figure Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Application in 2014
Figure Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Application in 2015
Figure Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Application in 2016
Figure Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Monoclonal Antibody Therapeutics
Figure United States Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Monoclonal Antibody Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure United States Monoclonal Antibody Therapeutics Market Size (Million USD) Share by Players in 2016
Figure United States Monoclonal Antibody Therapeutics Market Size (Million USD) Share by Players in 2017
Figure EU Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Monoclonal Antibody Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure EU Monoclonal Antibody Therapeutics Market Size (Million USD) Share by Players in 2016
Figure EU Monoclonal Antibody Therapeutics Market Size (Million USD) Share by Players in 2017
Figure Japan Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Monoclonal Antibody Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure Japan Monoclonal Antibody Therapeutics Market Size (Million USD) Share by Players in 2016
Figure Japan Monoclonal Antibody Therapeutics Market Size (Million USD) Share by Players in 2017
Figure China Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Monoclonal Antibody Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure China Monoclonal Antibody Therapeutics Market Size (Million USD) Share by Players in 2016
Figure China Monoclonal Antibody Therapeutics Market Size (Million USD) Share by Players in 2017
Figure India Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Monoclonal Antibody Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure India Monoclonal Antibody Therapeutics Market Size (Million USD) Share by Players in 2016
Figure India Monoclonal Antibody Therapeutics Market Size (Million USD) Share by Players in 2017
Figure Southeast Asia Monoclonal Antibody Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Monoclonal Antibody Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Monoclonal Antibody Therapeutics Market Size (Million USD) Share by Players in 2016
Figure Southeast Asia Monoclonal Antibody Therapeutics Market Size (Million USD) Share by Players in 2017
Figure Global Monoclonal Antibody Therapeutics Market Size (Million USD) (Value) by Regions (2017-2022)
Table Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Regions (2017-2022)
Figure Global Monoclonal Antibody Therapeutics Market Size (Million USD) Share by Regions in 2017
Figure Global Monoclonal Antibody Therapeutics Market Size (Million USD) Share by Regions in 2022
Figure United States Monoclonal Antibody Therapeutics Revenue and Growth Rate (2017-2022)
Figure EU Monoclonal Antibody Therapeutics Revenue and Growth Rate (2017-2022)
Figure Japan Monoclonal Antibody Therapeutics Revenue and Growth Rate (2017-2022)
Figure China Monoclonal Antibody Therapeutics Revenue and Growth Rate (2017-2022)
Figure India Monoclonal Antibody Therapeutics Revenue and Growth Rate (2017-2022)
Figure Southeast Asia Monoclonal Antibody Therapeutics Revenue and Growth Rate (2017-2022)
Table Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Type (2017-2022)
Figure Global Monoclonal Antibody Therapeutics Market Size (Million USD) Share by Type in 2017
Figure Global Monoclonal Antibody Therapeutics Market Size (Million USD) Share by Type in 2022
Table Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Application (2017-2022)
Figure Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Application in 2017
Figure Global Monoclonal Antibody Therapeutics Market Size (Million USD) by Application in 2022